BP
XRAY icon

Ballentine Partners’s Dentsply Sirona XRAY Stock Holding History

Ballentine Partners’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,341
Closed -$207K – 1097
2025
Q3 		$207K Sell
16,341
-13,891
-46% -$202K ﹤0.01% 901
2025
Q2 		$480K Buy
30,232
+16,167
+115% +$242K 0.01% 497
2025
Q1 		$210K Buy
+14,065
New +$249K ﹤0.01% 784
2017
Q3 		– Sell
-3,208
Closed -$203K – 468
2017
Q2 		$203K Buy
+3,208
New +$203K 0.01% 345

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Ballentine Partners's XRAY Position: Q4 2025 in Review

Ballentine Partners sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 16,341 shares — an estimated $207K sold.

Ballentine Partners first reported a position in XRAY in Q2 2017 and held it in 4 quarters. The position peaked at $480K in Q2 2025. 360 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

  • Ballentine Partners reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
  • Ballentine Partners sold 16,341 Dentsply Sirona shares in Q4 2025, an estimated $207K.
  • Ballentine Partners first reported a position in Dentsply Sirona in Q2 2017 and held it in 4 quarters.
  • Ballentine Partners's Dentsply Sirona position peaked at $480K in Q2 2025.
  • 360 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Ballentine Partners's 13F filing for Q4 2025, filed 3 Feb 2026.